VECTIPRO

Welcome to the Brand page for “VECTIPRO”, which is offered here for Biological preparations for use in medical and clinical gene therapy and cell therapy; clinical medical reagents for use in gene therapy, gene diagnosis, and gene testing; pharmaceutical preparations, vaccines for use in gene therapy; gene therapy and prophylaxis products, gene delivery, gene transfer, gene regulation and gene modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, cancer, inflammatory and auto-immune diseases, vascular disorders, and single gene disorders;.

Its status is currently believed to be active. Its class is unavailable. “VECTIPRO” is believed to be currently owned by “Amsterdam Molecular Therapeutics (AMT) B.V.”